Caffeine Consumption for Terbinafine Reaction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how drinking coffee affects people taking terbinafine, a medicine for toenail fungus (onychomycosis). Researchers aim to determine if caffeine alters blood pressure or heart rate when combined with the medication. Participants will drink either caffeinated or decaffeinated coffee. This trial suits those planning to start oral terbinafine treatment and who do not have anxiety or high blood pressure. As an unphased trial, it offers a unique opportunity to contribute to understanding the interaction between common beverages and medications.
Do I need to stop my current medications for this trial?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that mixing caffeine with terbinafine might cause some problems. Terbinafine can prolong caffeine's presence in the body, potentially affecting heart rate or blood pressure.
Terbinafine itself may cause common side effects, such as headaches, upset stomachs, or skin rashes. In rare cases, it can affect the liver and lead to serious issues.
The trial aims to determine if adding caffeine changes these effects. The trial phase is labeled "Not Applicable," indicating that the safety of the treatment is still under study.12345Why are researchers excited about this trial?
Researchers are excited about using caffeinated and decaffeinated coffee to explore how caffeine might affect reactions to terbinafine, a common antifungal medication. Unlike traditional treatments that focus solely on the medication itself, this trial looks at a simple dietary change—coffee consumption—as a way to potentially enhance or alter the drug's effectiveness. The unique aspect here is caffeine's potential impact on drug metabolism, which could lead to more personalized and effective treatment plans. This approach could offer a more accessible and natural method to optimize terbinafine's performance in treating fungal infections.
What evidence suggests that this trial's treatments could be effective for changes in blood pressure or heart rate?
This trial will compare the effects of caffeinated coffee with decaffeinated coffee in participants taking terbinafine. Research has shown that caffeine can impact blood pressure and heart rate, especially when combined with certain medications. Terbinafine, a common antifungal drug, might cause caffeine to remain in the body longer, potentially intensifying its effects on the heart and blood vessels. Although specific data on how this combination changes blood pressure or heart rate is not yet available, the concern exists because caffeine is known to raise these vital signs. People taking terbinafine often receive advice to limit caffeine to avoid possible side effects.16789
Who Is on the Research Team?
Shari Lipner, MD,PhD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a nail infection called onychomycosis who are about to begin treatment with terbinafine. It's not open to pregnant or breastfeeding individuals, those unable to consent, or anyone with a history of anxiety or high blood pressure.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume either caffeinated or decaffeinated coffee and are monitored for changes in heart rate and blood pressure
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Caffeinated Coffee
- Decaffeinated Coffee
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor